In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
After finishing at $0.41 in the prior trading day, Generation Bio Co (NASDAQ: GBIO) closed at $0.37, down -8.42%. In other words, the price has decreased by -$8.42 from its previous closing price. On the day, 0.57 million shares were traded.
Ratios:
Our goal is to gain a better understanding of GBIO by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.50 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 1.09 whereas as Long-Term Debt/Eq ratio is at 0.93.
On November 08, 2022, Canaccord Genuity started tracking the stock assigning a Buy rating and target price of $9.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 10 ’25 when Quinn Anthony G. bought 125,791 shares for $0.96 per share. The transaction valued at 120,759 led to the insider holds 214,286 shares of the business.
Quinn Anthony G. bought 85,000 shares of GBIO for $82,450 on Jan 13 ’25. The Director now owns 299,286 shares after completing the transaction at $0.97 per share. On Jul 01 ’24, another insider, Paone Antoinette, who serves as the CHIEF OPERATING OFFICER of the company, sold 6,719 shares for $2.74 each. As a result, the insider received 18,410 and left with 13,807 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.26 while its Price-to-Book (P/B) ratio in mrq is 0.29.
Stock Price History:
Over the past 52 weeks, GBIO has reached a high of $4.34, while it has fallen to a 52-week low of $0.32. The 50-Day Moving Average of the stock is -17.41%, while the 200-Day Moving Average is calculated to be -75.15%.
Shares Statistics:
A total of 66.97M shares are outstanding, with a floating share count of 45.79M. Insiders hold about 31.67% of the company’s shares, while institutions hold 64.05% stake in the company.
